Class action suit targets Novartis

Share this article:
A US judge has ruled that Novartis Pharmaceuticals will have to defend itself against sex-discrimination claims brought by a group of female sales reps in a $100 million class-action lawsuit.

Judge Gerald Lynch granted class-action status to a lawsuit in US District Court in Manhattan against Novartis by 19 current and former sales employees.

The lawsuit, filed in 2004, alleged Novartis' pharma unit was discriminatory in its pay, promotions, evaluations and treatment of women who take pregnancy leave. About 5,000 women are believed to qualify as plaintiffs.

A Novartis spokesman said in published reports at press time that lawyers were still reviewing related documents.  

Share this article:

Email Newsletters

More in News

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...